This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Lerman C , Caporaso NE , Audrain J , Main D , Boyd NR , Shields PG
Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence
Molecular Psychiatry. 2000 Mar;5(2) :189-192
AbstractIndividual differences in propensity to nicotine dependence appear to be mediated, in part, by genetic factors.' The serotonin transporter gene has a functional polymorphism (5- HTTLPR) which modulates gene transcription and reuptake.(2,3) A possible role in nicotine dependence is suggested by a link between 5-HTTLPR and neuroticism,(4) a personality trait which has been related to smoking practices.(5) In a cross-sectional study of 185 smokers, we utilized multiple linear regression modeling to examine the interacting effects of the 5-HTTLPR and neuroticism on smoking practices and nicotine dependence. Genotype was classified according to the presence or absence of the short (s) allele vs the long (I) allele of 5-HTTLPR tie, s/s or s/l vs I/I). Models controlled for gender, age, race, and alcohol use. The 5-HTTLPR by neuroticism interaction effect was statistically significant in the models of nicotine intake (P = 0.05), nicotine dependence (P = 0.001), and smoking motivations (smoking to reduce negative mood (P = 0.01); smoking for stimulation (P = 0.01)), The results suggested that neuroticism was positively associated with these smoking practices among smokers with 5-HTTLPR S genotypes (s/s or s/l), but not among smokers with the L genotype (I/I), The 5-HTTLPR may modify the effects of neuroticism on smoking motivations and nicotine dependence. Assessment of 5-HTTLPR genotype and neuroticism may help to identify smokers who are more responsive to psychotropic medications, such as selective serotonin reuptake inhibitors (SSRIs), which are being used in smoking cessation treatment.
NotesTimes Cited: 12 English Article 307AF MOL PSYCHIATR